top of page

Search

CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's

Social Media Coordinator
12 minutes ago
1 min read

Join other Boston ONS members for another excellent review of CAR-Therapy Adverse Reactions Review!

Click here to register!

Recent Posts

NOW HYBRID! Join BONS for another FREE CNE event sponsored by CEC Oncology

NOW HYBRID! Join BONS for another FREE CNE event sponsored by CEC Oncology

NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1

NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1

BONS Half Day Seminar ~ It's around the corner

BONS Half Day Seminar ~ It's around the corner

Comments

bottom of page